Pages that link to "Q40325350"

The following pages link to Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells. (Q40325350):

Displaying 21 items.

• Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth (Q24651313) (← links)
• Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations (Q27027491) (← links)
• Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies (Q33691759) (← links)
• Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions (Q34077808) (← links)
• Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target (Q34395370) (← links)
• Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment (Q35104726) (← links)
• Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma. (Q35679424) (← links)
• Prediction of drugs having opposite effects on disease genes in a directed network. (Q35906133) (← links)
• Approach to the patient with anaplastic thyroid carcinoma (Q36134835) (← links)
• The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer (Q37209593) (← links)
• Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation (Q37365523) (← links)
• Targeted therapies and thyroid cancer (Q37825764) (← links)
• Anaplastic thyroid cancer: a comprehensive review of novel therapy (Q37854708) (← links)
• Emerging therapies for thyroid carcinoma (Q37974717) (← links)
• Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo (Q38734526) (← links)
• Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells (Q39364331) (← links)
• Advances in small molecule therapy for treating metastatic thyroid cancer. (Q39364787) (← links)
• HIF-1α and HSP90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line (Q39431582) (← links)
• Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines. (Q40079882) (← links)
• Furano‐1,2‐naphthoquinone inhibits EGFR signaling associated with G2/M cell cycle arrest and apoptosis in A549 cells (Q42793400) (← links)
• Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway (Q91940109) (← links)